Sino Biopharmaceutical Stock Price, News & Analysis

SBHMY OTC Link

Company Description

Welcome to the overview page for Sino Biopharmaceutical (SBHMY), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

118.6 %

Performance 1 year

$19.4B

Market Cap

938.0M

Shares outstanding

Latest News

View All

May 5, 2025

46.84%

Global First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial

clinical trial

August 6, 2021

0.00%

Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China

SEC Filings

View All

No SEC filings available for Sino Biopharmaceutical.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Sino Biopharmaceutical (SBHMY)?

The current stock price of Sino Biopharmaceutical (SBHMY) is $18.22 as of November 26, 2025.

What is the market cap of Sino Biopharmaceutical (SBHMY)?

The market cap of Sino Biopharmaceutical (SBHMY) is approximately 19.4B. Learn more about what market capitalization means .